DC
AVDL

Deere & Company’s Avadel Pharmaceuticals AVDL Stock Holding History

Deere & Company’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43,887
Closed -$544K – 78
2016
Q3 		$544K Hold
43,887
– – 0.03% 568
2016
Q2 		$471K Hold
43,887
– – 0.03% 632
2016
Q1 		$485K Buy
43,887
+7,673
+21% +$76.2K 0.03% 624
2015
Q4 		$442K Buy
36,214
+12,162
+51% +$190K 0.03% 612
2015
Q3 		$392K Buy
+24,052
New +$530K 0.02% 674

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Deere & Company's AVDL Position: Q4 2016 in Review

Deere & Company sold out of Avadel Pharmaceuticals (AVDL) in Q4 2016, closing a stake of 43,887 shares — an estimated $544K sold.

Deere & Company first reported a position in AVDL in Q3 2015 and held it in 5 quarters. The position peaked at $544K in Q3 2016. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

  • Deere & Company reported no remaining Avadel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 43,887 Avadel Pharmaceuticals shares in Q4 2016, an estimated $544K.
  • Deere & Company first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Deere & Company's Avadel Pharmaceuticals position peaked at $544K in Q3 2016.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.